A suppressive role of guanine nucleotide-binding protein subunit beta-4 inhibited by DNA methylation in the growth of anti-estrogen resistant breast cancer cells

Gnb isoforms control a signaling pathway comprising Rac1, Plc 2, and Plc 3 leading to LFA-1 activation and neutrophil arrest in vivo

(2015) H. Block et al.   BLOOD

Altered radiation responses of breast cancer cells resistant to hormonal therapy

(2015) Lidiya Luzhna et al.   Oncotarget

Recent advances in Charcot–Marie–Tooth disease

(2014) Jonathan Baets et al.   CURRENT OPINION IN NEUROLOGY

A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells

(2014) S Thrane et al.   ONCOGENE

Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

(2014) D Elias et al.   ONCOGENE

Exome Sequencing Identifies GNB4 Mutations as a Cause of Dominant Intermediate Charcot-Marie-Tooth Disease

(2013) Bing-Wen Soong et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Estrogen receptor α is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling

(2013) Susan Thrane et al.   BREAST CANCER RESEARCH AND TREATMENT

Cdks, cyclins and CKIs: roles beyond cell cycle regulation

(2013) S. Lim et al.   DEVELOPMENT

Insight into the mechanisms of action of estrogen receptor β in the breast, prostate, colon, and CNS

(2013) Prasenjit Dey et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Drosophila p53 isoforms differentially regulate apoptosis and apoptosis-induced proliferation

(2012) M-L Dichtel-Danjoy et al.   CELL DEATH AND DIFFERENTIATION

Compensatory proliferation and apoptosis-induced proliferation: a need for clarification

(2012) B Mollereau et al.   CELL DEATH AND DIFFERENTIATION

Mitotic and mitogenic Wnt signalling

(2012) Christof Niehrs et al.   EMBO JOURNAL

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

(2012) Christina Davies et al.   LANCET

Speedy/Ringo C regulates S and G2phase progression in human cells

(2011) Aiyang Cheng et al.   CELL CYCLE

Coordination of mitosis and morphogenesis: role of a prolonged G2 phase during chordate neurulation

(2011) Y. Ogura et al.   DEVELOPMENT

Genome-Wide Mapping of Estrogen Receptor-β–Binding Regions Reveals Extensive Cross-Talk with Transcription Factor Activator Protein-1

(2010) Chunyan Zhao et al.   CANCER RESEARCH

Phosphorylation and Acetylation of Histone H3 and Autoregulation by Early Growth Response 1 Mediate Interleukin 1β Induction of Early Growth Response 1 Transcription

(2009) Bo Wang et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Identification of a Putative Protein Profile Associated with Tamoxifen Therapy Resistance in Breast Cancer

(2009) Arzu Umar et al.   MOLECULAR & CELLULAR PROTEOMICS

Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant

(2008) Thomas Frogne et al.   BREAST CANCER RESEARCH AND TREATMENT

Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function

(2008) S. Massarweh et al.   CANCER RESEARCH

Characterization of intron-1 haplotypes of the G protein β4 subunit gene – association with survival and progression in patients with urothelial bladder carcinoma

(2008) Kathrin Riemann et al.   Pharmacogenetics and Genomics

Heterotrimeric G protein activation by G-protein-coupled receptors

(2007) William M. Oldham et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY